Sagility Share Price in Focus; Promoter Offloads 16.4% Stake, 51% Holding Retained After Sale

Sagility, a provider of technology-enabled business services in the US healthcare sector, witnessed a significant shift in ownership as its Netherlands-based promoter Sagility B V sold a 16.4% stake on November 14, 2025.  

The transaction attracted attention from several global and domestic institutional investors who picked up 8.6% of the equity stake. 

Large-Scale Stake Sale by Sagility B V 

On November 14, 2025, Sagility B V offloaded 76.9 crore equity shares, representing 16.4% of the company's paid-up equity, via open market deals. The shares were sold at ₹47.6 apiece, totalling a transaction value of ₹3,660.44 crore. Following this move, the promoter's shareholding dropped from 67.38% to nearly 51%. 

Buyers of the Stake and Amount Acquired 

Multiple institutional players participated in the acquisition. Unifi Capital, along with its Unifi Blend Fund 2, bought 22.05 crore shares, equating to a 4.71% stake, at ₹1,049.65 crore. ICICI Prudential Mutual Fund acquired 3.13 crore shares for ₹149.39 crore, while Societe Generale picked up 8.48 crore shares at ₹403.75 crore. 

Read More: New World Fund Sells 2.09% Stake in PB Fintech! 

Additional Institutional Participation 

Further, Norges Bank, acting for the Government Pension Fund Global, acquired 3.71 crore shares for ₹176.59 crore. Morgan Stanley Asia Singapore also participated, purchasing 2.76 crore shares valued at ₹131.47 crore.  

Sagility Share Price Performance 

On November 17, 2025, Sagility share price opened at ₹52.89 on NSE, below the previous close of ₹53.28. During the day, it surged to ₹53.68 and dipped to ₹52.60. The stock is trading at ₹53.00 as of 9:48 AM. The stock registered a moderate decline of 0.53%. 

 Over the past week, it has moved up by 5.96%, over the past month, it has moved up by 17.53%, and over the past 3 months, it has moved up by 15.71%. 

Conclusion 

The recent stake sale marks an important phase for Sagility, reducing promoter holding while attracting reputed institutional investors. The transaction demonstrates continued investor interest in companies engaged in healthcare services, even during promoter exits. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.